Effects of human umbilical cord blood mononuclear cells on ovalbumin-induced asthma in mice
Journal of Thoracic Disease · 2023-10 · 15 (10) · 5454-5465
DOI: 10.21037/jtd-22-1669 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thoracic Disease, 2023-10. Verfasst von Yu-Long Luo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Innovation Centre for Advanced Interdisciplinary Medicine, Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong …. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Umbilical cord blood mononuclear cells (UCMNCs) show broad immune-modulation effects, which may be helpful for treating asthma. Effects of UCMNCs on asthma were investigated with mouse model in present study.
Methods
Asthma was induced in BALB/c mice by ovalbumin (OVA) immunization and challenge. Asthmatic mice were then treated on days 7 and 20 with intravenous injections of UCMNCs in doses of 4×105, 2×106, and 107 cells per mouse for the low-dose UCMNC (UCMNCL), medium-dose UCMNC (UCMNCM), and high-dose UCMNC (UCMNCH) groups, respectively. Fetal mouse blood mononuclear cells (FMMNCs) were administered to FMMNC group at a dose of 2×106 cells per mouse as approximate allograft control. Airway hyperresponsiveness (AHR), airway inflammation indexes, and CD4/CD8 T cell subsets were measured at day 25.
Results
Compared with the model group, AHR in the UCMNCL group, inflammation score of lung tissue in the UCMNCM group, interleukin (IL)-5 in bronchoalveolar lavage fluid (BALF) in UCMNCL group, IL-5 and IL-13 in BALF in UCMNCM group, and IL-17 in serum in UCMNCH group were significantly inhibited. Compared with the model group, CD4+CD8+ T cells were reduced in the UCMNCL group, while decrease of CD4-CD8- T cells and increase of CD4+CD8- T cells were further strengthened in UCMNCM group. FMMNC treatment significantly reduced the IL-13 and IL-17 in serum, decreased CD4-CD8- and CD4+CD8- T cells, and increased the CD4+CD8+ and CD4-CD8+ T cells in BALF.
Conclusions
UCMNCs can modulate AHR, T-helper (Th)2 inflammation, and airway injury in experimental asthma at appropriate dose.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Innovation Centre for Advanced Interdisciplinary Medicine, Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, the Fifth Affiliated Hospital of Guangzho…
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou…
- Guangdong Laboratory Animals Monitoring Institute, Guangdong Provincial Key Laboratory of Laboratory Animals, Guangzhou, China.
Zitieren
APA
Luo, Y. L., Li, Y. F., Zhu, Y. P., Liang, J. Q., Chen, D. F., Chen, H. J., Huang, C. Q., Li, J., & Li, S. Y. (2023). Effects of human umbilical cord blood mononuclear cells on ovalbumin-induced asthma in mice. Journal of Thoracic Disease, 15(10), 5454-5465. https://doi.org/10.21037/jtd-22-1669
Vancouver
Luo YL, Li YF, Zhu YP, Liang JQ, Chen DF, Chen HJ, et al. Effects of human umbilical cord blood mononuclear cells on ovalbumin-induced asthma in mice. Journal of Thoracic Disease. 2023;15(10):5454-5465. doi:10.21037/jtd-22-1669
BibTeX
@article{Luo2023,
author = {Luo, Yu-Long and Li, Yun-Feng and Zhu, Yi-Ping and Liang, Jin-Qiang and Chen, Di-Fei and Chen, Huan-Jie and Huang, Chu-Qing and Li, Jing and Li, Shi-Yue},
title = {Effects of human umbilical cord blood mononuclear cells on ovalbumin-induced asthma in mice},
journal = {Journal of Thoracic Disease},
year = {2023},
volume = {15},
number = {10},
pages = {5454--5465},
doi = {10.21037/jtd-22-1669}
}
EUVIMED